Skip to main content
. 2023 Apr 24;15(5):1329. doi: 10.3390/pharmaceutics15051329

Figure 1.

Figure 1

Genome-editing Nucleases. (A) Schematic depicting ZFN and TALEN genome-editing systems and the resulting DSB. (B) Schematic depicting the CRISPR-Cas9 genome-editing systems and the resulting DSB.